避孕藥市場按類型、給藥途徑、年齡層、分銷管道和地區分類

2025 年全球避孕藥具市場規模估計為 197.9 億美元，預計到 2032 年將達到 471.4 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 13.2%。

數字。 2025年各地區避孕市場佔有率（%）

過去幾十年來，全球避孕藥市場一直穩定成長。避孕藥，俗稱避孕藥，含有合成的女性荷爾蒙雌激素和黃體素。透過口服來抑制排卵和改變子宮頸黏液和子宮內膜以防止懷孕。對計劃生育態度的轉變、對意外懷孕的日益擔憂、對性健康的認知的提高以及對避孕選擇的更嚴格的監管規範都在推動全球對避孕藥具的需求。此外，女性勞動參與率的提高和懷孕時間的延遲也進一步提高了口服避孕藥的接受度。

市場動態：

婦女識字率的提高和婦女權力的增強是推動避孕市場向前發展的主要因素。隨著人們對婦女生殖健康和權利意識的提高，人們廣泛接受使用避孕藥來延遲或計劃懷孕。快速的都市化、不斷變化的生活方式以及現代醫療保健的便捷，使得越來越多的女性選擇口服避孕藥。同時，功效更高、副作用更少的新產品的出現以及滿足避孕方面未滿足的醫療需求的技術創新正在為市場參與者創造豐厚的成長機會。然而，替代性計劃生育方法和避孕設備的可用性，以及與荷爾蒙藥物相關的副作用（如血栓、憂鬱症和體重減輕）正在阻礙市場的成長。此外，社會恥辱和宗教保留繼續抑制某些地區對避孕藥具的需求。

本研究的主要特點

• 本報告對全球避孕藥具市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率(CAGR)。
• 它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要市場參與者採用的競爭策略的重要見解。
• 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球避孕藥具市場的主要企業概況。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球避孕藥具市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 透過分析全球避孕藥具市場所使用的各種策略矩陣，相關人員將發現決策更加容易。

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
• 避孕藥具日益普及
• 加強政府力度，促進計劃生育和避孕措施的普及
  • 限制因素
• 與錠劑相關的副作用
• 血栓和心血管疾病的風險
  • 機會
• 新興國家的需求不斷成長
• 選擇避孕的女性人口不斷增加
• 主要亮點
• 近期動態
• PEST分析
• 波特分析
• 最近的產品核可/發布
• 合併、收購和合作

4. 全球避孕市場-冠狀病毒（COVID-19）大流行的影響

• COVID-19流行病學
• 供需側分析
• 經濟影響

5. 2020-2032 年全球避孕藥市場（按類型）

• 合併避孕藥
• 單錠劑
• 多錠劑
• 延長週期藥丸
• 荷爾蒙避孕藥
• 僅含黃體素的避孕藥
• 事後緊急避孕藥
• levonorgestrel類
• 醋酸烏利司他鹼

6. 2020-2032 年全球避孕藥市場（依給藥途徑分類）

• 口服
• 注射
• 在子宮內
• 陰道
• 其他（補丁等）

7. 2020-2032 年全球避孕市場（依年齡層分類）

• 青年
• 成人

8. 2020-2032 年全球避孕藥市場（依分銷管道分類）

• 網路藥局
• 醫院藥房
• 零售藥局

9. 2020-2032 年全球避孕藥市場（按地區）

• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東
• 非洲

第10章 競爭格局

• 公司簡介
  • Bayer AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries
  • Merck &Co.
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players

第 11 章 章節

• 參考
• 調查方法
• 關於出版商

Global Contraceptives Market is estimated to be valued at USD 19.79 Bn in 2025 and is expected to reach USD 47.14 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.2% from 2025 to 2032.

Figure. Contraceptives Market Share (%), By Region 2025

Global contraceptive pill market has been witnessing steady growth over the past few decades. Contraceptive pills, commonly known as birth control pills, contain synthetic versions of the female sex hormones - estrogen and progesterone. They are taken orally to prevent pregnancy by inhibiting ovulation and altering cervical mucus and the lining of the uterus. Changing attitudes towards family planning, rising concern about unplanned pregnancies, growing sexual health awareness, and stricter regulatory norms regarding contraceptive options have boosted the demand for contraceptive pills globally. Moreover, increasing women workforce participation and delayed pregnancies have further augmented the acceptance of oral contraceptive drugs.

Market Dynamics:

Rising female literacy and empowerment are the primary drivers propelling the contraceptive pill market forward. Growing awareness about women's reproductive health and rights has led to a widespread acceptance of contraceptives to delay or plan pregnancies. Rapid urbanization, changing lifestyles, and easier access to modern healthcare are encouraging more women to opt for oral contraceptives. At the same time, the emergence of new products with improved efficacy and fewer side effects as well as innovations to address unmet medical needs in contraception are creating lucrative growth opportunities for market players. However, the presence of alternative family planning methods and contraceptive devices along with some side effects that are associated with hormonal pills such as blood clots, depression, and weight changes are hindering the market growth. Moreover, social stigma and religious reservations in some regions continue to restrain the demand for contraceptive pills.

Key Features of the Study:

• This report provides an in-depth analysis of the global contraceptive market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key market players
• It profiles key players in the global contraceptive market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries, Merck & Co., Janssen Pharmaceutical Companies, Allergan, Piramal Enterprises, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Mithra Pharmaceuticals, Gedeon Richter, HLL Lifecare, Cadila Healthcare, Organon and Other Prominent Players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive market

Detailed Segmentation:

• Global Contraceptive Market, By Type
  • Combination Contraceptives
  • Monophasic pills
  • Multiphasic pills
  • Extended-cycle pills
  • Hormonal Contraceptives
  • Progestin-Only Pills
  • Emergency Contraceptives
  • Levonorgestrel-based
  • Ulipristal acetate-based
• Global Contraceptive Market, By Route of Administration
  • Oral
  • Injectable
  • Intrauterine
  • Vaginal
  • Others (Patches, etc.)
• Global Contraceptive Market, By Age Group
  • Adolescents
  • Adults
• Global Contraceptive Market, By Distribution Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
• Global Contraceptive Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Bayer AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries
  • Merck & Co.
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Age Group
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers:
• Increasing popularity of contraceptive drugs
• Growing government initiatives for promoting access to family planning and contraceptives
  • Restraints
• Side effects associated with pills
• Risks of blood clots and cardiovascular diseases
  • Opportunities
• Growing demand in developing countries
• Growing female population opting for contraceptive drugs
• Key Highlights
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Recent Product Approvals/Launches
• Mergers, Acquisitions, and Collaborations

4. Global Contraceptive Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Contraceptive Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Combination Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Monophasic pills
• Multiphasic pills
• Extended-cycle pills
• Hormonal Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Progestin-Only Pills
• Emergency Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Levonorgestrel-based
• Ulipristal acetate-based

6. Global Contraceptive Market, By Route of Administration, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Intrauterine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Vaginal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others (Patches, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Contraceptive Market, By Age Group, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adolescents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Contraceptive Market, By Distribution Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Contraceptive Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Bayer AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Pfizer Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Teva Pharmaceutical Industries
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Merck & Co.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players
• Analyst Views

11. Section

• References
• Research Methodology
• About us